|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1139647837 |
003 |
OCoLC |
005 |
20231120010436.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
200209s2020 enka ob 001 0 eng d |
040 |
|
|
|a YDX
|b eng
|e rda
|e pn
|c YDX
|d OPELS
|d OCLCF
|d UKMGB
|d UKAHL
|d N$T
|d EBLCP
|d CNCGM
|d BWN
|d NRC
|d OCLCO
|d OCLCA
|d IWU
|d OCLCO
|d OCLCQ
|d OCLCO
|d SFB
|d OCLCQ
|d OCLCO
|
015 |
|
|
|a GBB9I2429
|2 bnb
|
016 |
7 |
|
|a 019602954
|2 Uk
|
019 |
|
|
|a 1139883338
|
020 |
|
|
|a 9780128198834
|q (electronic bk.)
|
020 |
|
|
|a 0128198834
|q (electronic bk.)
|
020 |
|
|
|z 9780128198827
|q (print)
|
020 |
|
|
|z 0128198826
|
035 |
|
|
|a (OCoLC)1139647837
|z (OCoLC)1139883338
|
050 |
|
4 |
|a RC382
|b .O25 2020eb
|
060 |
|
4 |
|a WL 359
|
082 |
0 |
4 |
|a 616.8/33061
|2 23
|
100 |
1 |
|
|a Obulesu, Magisetty,
|e author.
|
245 |
1 |
0 |
|a Parkinson's disease therapeutics :
|b emphasis on nanotechnological advances /
|c Magisetty Obulesu.
|
264 |
|
1 |
|a London, United Kingdom :
|b Academic Press, an imprint of Elsevier,
|c [2020]
|
300 |
|
|
|a 1 online resource (xiii, 131 pages) :
|b color illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed June 22, 2021).
|
650 |
|
0 |
|a Parkinson's disease
|x Chemotherapy.
|
650 |
|
2 |
|a Parkinson Disease
|x drug therapy
|0 (DNLM)D010300Q000188
|
650 |
|
6 |
|a Maladie de Parkinson
|x Chimioth�erapie.
|0 (CaQQLa)201-0271021
|
650 |
|
7 |
|a Parkinson's disease
|x Chemotherapy
|2 fast
|0 (OCoLC)fst01053695
|
776 |
0 |
8 |
|i Print version:
|z 9780128198834
|
776 |
0 |
8 |
|i Print version:
|z 0128198826
|z 9780128198827
|w (OCoLC)1111959985
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128198827
|z Texto completo
|